Difference between revisions of "Rezum"
Jump to navigation
Jump to search
(create) |
|||
| Line 1: | Line 1: | ||
'''Rezum''' a treatment for [[benign prostatic hyperplasia]] (BPH).<ref>{{cite journal |authors=Westwood J, Geraghty R, Jones P, Rai BP, Somani BK |title=Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia |journal=Ther Adv Urol |volume=10 |issue=11 |pages=327–333 |date=November 2018 |pmid=30344644 |pmc=6180381 |doi=10.1177/1756287218793084 |url=}}</ref> | '''Rezum''' is a treatment for [[benign prostatic hyperplasia]] (BPH) that uses water vapour.<ref>{{cite journal |authors=Westwood J, Geraghty R, Jones P, Rai BP, Somani BK |title=Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia |journal=Ther Adv Urol |volume=10 |issue=11 |pages=327–333 |date=November 2018 |pmid=30344644 |pmc=6180381 |doi=10.1177/1756287218793084 |url=}}</ref> | ||
==See also== | ==See also== | ||
Revision as of 17:00, 17 November 2022
Rezum is a treatment for benign prostatic hyperplasia (BPH) that uses water vapour.[1]
See also
References
- ↑ Westwood J, Geraghty R, Jones P, Rai BP, Somani BK (November 2018). "Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia". Ther Adv Urol 10 (11): 327–333. doi:10.1177/1756287218793084. PMC 6180381. PMID 30344644. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180381/.